Health News
Understanding Breast Cancer Genes
Between 5 and 10 percent of breast cancer cases have a genetic basis. While it might be tempting to know whether you have a mutated breast cancer gene, genetic testing is only recommended for people with certain risk factors.
Cancer Screening May Not Benefit Elderly
Regular cancer screenings are widely regarded as an important part of preventive medicine, particularly for people in midlife. But those same screenings might cause more harm than good in older patients facing a limited life expectancy.
HPV Vaccine May Have Staying Power
Not only does the HPV vaccine protect against human papillomavirus, but it also reduces the risk of cancers caused by HPV. Yet it only protects a person if it lasts long enough.
Extra Weight May Increase Risk for Certain Cancers
Many people want to slim down to cut their risks for heart disease and diabetes, but a new study suggests that being overweight may also affect cancer risk.
Pulmonary Disease May Increase Lung Cancer Risk
Medical conditions that affect breathing can take an immediate toll on health and may set the stage for other serious problems later in life.
Brisk Exercise May Cut Breast Cancer Risk in Black Women
Exercise has been associated with many health benefits like reduced heart disease risk and stress. And new research suggests black women may be able to cut their breast cancer risk by working out.
NSAIDs May Reduce Risk of Breast Cancer Recurrence
Overweight or obese women may be less likely to see their hormone-related breast cancer return if they take a common over-the-counter medication.
FDA Approves New Device to Preserve Donated Lungs
The US Food and Drug Administration (FDA) has approved a new device to preserve donated lungs. According to the agency, the device might lead to more lung transplants.
Screening for Colorectal Cancer May Reduce Risk, Death
Colorectal cancers are often highly treatable and preventable, particularly with regular screenings. One type of screening may reduce the rate of these cancers.
Cologuard Gets US Approval for Colorectal Cancer Screening
The U.S. Food and Drug Administration today approved Cologuard, the first stool-based colorectal screening test that detects the presence of red blood cells and DNA mutations that may indicate the presence of certain kinds of abnormal growths that may be cancers such as colon cancer or precursors to cancer.